Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200000 participants
OBSERVATIONAL
2022-11-17
2032-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence
NCT01004562
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT00898131
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703
Breast Cancer Survivorship Biorepository
NCT05786664
Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project
NCT01295658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.
* Individuals must be currently residing in the United States or a territory of the United States.
* Individuals must be able to read and understand English.
Exclusion Criteria
* Individuals without a diagnosis of breast cancer.
* Individuals who are not residing in the United States or a territory of the United States.
* Individuals unable to read and understand English.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Susan G. Komen Breast Cancer Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jerome Jourquin, Ph.D., M.S.
Role: PRINCIPAL_INVESTIGATOR
Susan G. Komen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Susan G. Komen
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SGK-SFC-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.